Related Experiment Videos

Clinical study on the hypotensive effect of diltiazem hydrochloride

International Journal of Clinical Pharmacology, Therapy, and Toxicology
|February 1, 1981
PubMed

Insights

Diltiazem HCl effectively lowers blood pressure in essential hypertension patients. It also enhances the effect of trichlormethiazide in non-responsive individuals, with minimal side effects.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Essential hypertension is a prevalent cardiovascular condition requiring effective management.
  • Diltiazem hydrochloride (HCl) is a calcium channel blocker used for hypertension treatment.

Purpose of the Study:

  • To investigate the hypotensive efficacy of Diltiazem HCl in patients with essential hypertension.
  • To evaluate the combined effect of Diltiazem HCl and trichlormethiazide in non-responsive patients.

Main Methods:

  • Oral administration of Diltiazem HCl at a fixed daily dose of 180 mg.
  • Assessment of systolic and diastolic blood pressure changes.
  • Evaluation of concurrent Diltiazem HCl and trichlormethiazide therapy.

Main Results:

  • Diltiazem HCl alone reduced systolic pressure in 88.9% and diastolic pressure in 66.7% of patients.
  • Concurrent use with trichlormethiazide improved blood pressure control in non-responders.
  • Reported side effects (gastric fullness, dizziness) were mild and transient.

Conclusions:

  • Diltiazem HCl demonstrates significant clinical efficacy as a hypotensive agent.
  • Combination therapy with trichlormethiazide expands treatment options for essential hypertension.
  • Diltiazem HCl is well-tolerated in the clinical setting.

Related Concept Videos